Germany’s Merck KGaA today announced that Dr Luciano Rossetti will be retiring as global head of R&D for the Healthcare business sector. 15 October 2020
US pharma giant Merck & Co on Friday announced that Roger Perlmutter will be retiring as executive vice president and president, Merck Research Laboratories (MRL). 5 October 2020
Germany’s Merck KGaA today announced that next year Dr Stefan Oschmann, chairman of the firm’s executive board of Merck, will hand over the position to Dr Belén Garijo, who will also become chief executive on May 1, 2021. 28 September 2020
French drugmaker Ipsen today announced the appointment of Philippe Lopes-Fernandes as executive vice president, chief business officer, effective October 1, 2020. 25 September 2020
Privately-held Danish medical dermatology specialist LEO Pharma today said that Becki Morison will join the company, effective October 1 in the position of executive vice president, global therapeutics and value strategy. 23 September 2020
While revenues declined 2% to $5.4 billion, USA-based drugmaker Eli Lilly beat profit forecasts for the second quarter of 2020, the firm announced on Thursday. 30 July 2020
Growing revenues and profitability in step with pipeline development, British drugmaker AstraZeneca posted an upbeat second quarter results statement on Thursday, with a strong focus on efforts to combat the novel coronavirus. 30 July 2020
Despite second quarter sales being undercut by the coronavirus pandemic, French drugs and vaccines specialist Sanofi has raised its projection for the year, spurred by cost cutting measures and the sale of its stake in Regeneron Pharmaceuticals. 29 July 2020
LEO Pharma’s UK and Ireland business has appointed a new medical affairs lead, Amit Aggarwal, formerly director of UK medical affairs at Bayer. 23 July 2020
Following the appointment of Haseeb Ahmad to the role of global head of value and access and commercial development, Chinmay Bhatt has taken on the position of managing director UK, Ireland & Nordics for Novartis. 21 July 2020
Privately-held Danish medical dermatology specialist LEO Pharma today announced that Dr Monica Shaw and Nathalie Joannes will join the executive leadership team adding seasoned experience and international profile to the company. 1 July 2020
UK-based Indivior’s shares rose nearly 4% to 79.05 pence in early trading, after it announced that, effective today, Mark Crossley is appointed chief executive. However, the stock was down 1% at 78.00 pence by late morning. 29 June 2020
The European Medicines Agency (EMA) Management Board has announced its nomination for the new executive director of the Agency to replace the outgoing Professor Guido Rasi, who is due to end his term in the position that he has held since 2011 (minus an off-stint due to a controversy over the selection procedure). 25 June 2020
Mundipharma today announced that Marc Princen has joined the Mundipharma network of independently associated companies as the global chief executive, effective June 1, 2020. 15 June 2020
As part of an R&D overhaul, Copenhagen-based CNS specialist Lundbeck has announced plans to reduce its headcount by around 150, mostly in Denmark. 9 June 2020
On Friday, US President Donald Trump announced the addition of two of the most highly respected and skilled professionals to the White House new initiative, dubbed Operation Warp Speed, the objective of which is to finish developing and then to manufacture and distribute a proven coronavirus vaccine as fast as possible. 16 May 2020
Swiss pharma giant Roche today announced that, on May 10, Dr Fritz Gerber, a formative figure in the company’s history, died in his 92nd year. 11 May 2020
New Jersey, USA-based rare disease drug developer PTC Therapeutics today announced the appointments of Matthew Klein to chief development officer and Eric Pauwels to chief business officer. 17 April 2020
H3 Biomedicine, the USA-based precision medicine subsidiary of Japanese drugmaker Eisai, has named industry veteran Antonio Gualberto its chief medical officer (CMO). 20 February 2020
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024
Lykos Therapeutics has announced a reorganization to best support the company as it works to address the resubmission of its new drug application (NDA) for midomafetamine capsules for the treatment of post-traumatic stress disorder (PTSD) in adults. 16 August 2024
German infectious disease specialist AiCuris Anti-infective Cures has announced the appointment of Cynthia Wat as chief medical officer (CMO). 30 July 2024
Ophirex, a registered public benefit corporation developing an oral field treatment to address the global unmet medical needs of snakebite victims, has announced the appointment of Jeremy Gowler as chief executive. 15 July 2024
US drugmaker AbbVie has announced that Roopal Thakkar, who currently serves as senior vice president, chief medical officer, global therapeutics, has been appointed to the position of executive vice president, research and development, and chief scientific officer (CSO). 10 July 2024